Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-κb pathway

Journal of Ethnopharmacology

Volumn 186, Issue , 2016, Pages 20-29

  Mao, Hao Ping ^a   Wang, Xing Ye ^a   Gao, Yun Hang ^a   Chang, Yan Xu ^a   Chen, Lu ^a   Niu, Zi Chang ^b   Ai, Ju Qing ^a   Gao, Xiu Mei ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b FIRST TEACHING HOSPITAL OF TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cardiac hypertrophy; Danhong injection; NF b; p38

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; DANHONG INJECTION; HERBACEOUS AGENT; ISOPRENALINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ECHOCARDIOGRAPHY; FETUS; GEL MOBILITY SHIFT ASSAY; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; IN VITRO STUDY; IN VIVO STUDY; ISOPROTERENOL-INDUCED CARDIAC HYPERTROPHY; MALE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CARDIOMEGALY; CELL LINE; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; FLOWER; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYTOTHERAPY; RHIZOME; SAFFLOWER; SALVIA MILTIORRHIZA; WISTAR RAT;

ANIMALS; CARDIOMEGALY; CARTHAMUS TINCTORIUS; CELL LINE; FLOWERS; GENE EXPRESSION REGULATION; ISOPROTERENOL; MALE; MEDICINE, CHINESE TRADITIONAL; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; RHIZOME; SALVIA MILTIORRHIZA;

EID: 84962660085     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2016.03.015     Document Type: Article

References (53)

1. G. Abdelhamid, and A.O. El-Kadi Buthionine Sulfoximine, an inhibitor of Glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: roles of the NF-kappaB and MAPK signaling pathways Free Radic. Biol. Med. 82 2015 1 12
2. E.L. Alderman, and D.C. Harrison Myocardial hypertrophy resulting from low dosage Isoproterenol administration in rats Proc. Soc. Exp. Biol. Med. 136 1971 268 270
3. Y.X. Chang, X.P. Ding, J. Qi, J. Cao, L.Y. Kang, D.N. Zhu, B.L. Zhang, and B.Y. Yu The antioxidant-activity-integrated fingerprint: an advantageous tool for the evaluation of quality of herbal medicines J. Chromatogr. A 1208 2008 76 82
4. J. Chen, J. Deng, Y. Zhang, J. Yang, Y. He, W. Fu, P. Xing, and H. Wan Lipid-lowering effects of Danhong injection on hyperlipidemia rats J. Ethnopharmacol. 154 2014 437 442
5. Y. Chen, M. Liu, T. Zhao, B. Zhao, L. Jia, Y. Zhu, B. Zhang, X. Gao, G. Li, X. Li, R. Xiang, J. Han, and Y. Duan Danhong injection inhibits the development of atherosclerosis in both Apoe(-)/(-) and Ldlr(-)/(-) mice J. Cardiovasc. Pharmacol. 63 2014 441 452
6. S.J. Crampton, and G.W. O'Keeffe NF-kappaB: emerging roles in hippocampal development and function Int. J. Biochem. Cell Biol. 45 2013 1821 1824
7. X.J. Feng, H. Gao, S. Gao, Z.M. Li, H. Li, J. Lu, J.J. Wang, X.Y. Huang, M. Liu, J. Zou, J.T. Ye, and P.Q. Liu The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1 Br. J. Pharmacol. 172 2015 2852 2863
8. C. Freund, R. Schmidt-Ullrich, A. Baurand, S. Dunger, W. Schneider, P. Loser, A. El-Jamali, R. Dietz, C. Scheidereit, and M.W. Bergmann Requirement of nuclear factor-kappa B in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo Circulation 111 2005 2319 2325
9. N. Frey, and E.N. Olson Cardiac hypertrophy: the good, the bad, and the ugly Annu. Rev. Physiol. 65 2003 45 79
10. Y. Fu, H. Xiao, and Y. Zhang Beta-Adrenoceptor signaling pathways mediate cardiac pathological remodeling Front. Biosci. (Elite Ed.) 4 2012 1625 1637
11. G. Grassi Sympathetic overdrive and cardiovascular risk in the metabolic syndrome Hypertens. Res. 29 2006 839 847
12. L.A. Grisanti, A.A. Repas, J.A. Talarico, J.I. Gold, R.L. Carter, W.J. Koch, and D.G. Tilley Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic beta-adrenergic receptor stimulation Am. J. Physiol.-Heart Circ. Physiol. 308 2015 H316 H330
13. D.K. Gupta, and T.J. Wang Natriuretic peptides and Cardiometabolic health Circ. J.: Off. J. Jpn. Circ. Soc. 79 2015 1647 1655
14. He, T., Guan, A., Shi, Y., Ge, Z., Dai, H., 2015. Mitochondrial coupling factor 6 upregulation in hypertension-induced cardiac hypertrophy. Herz
15. B. Kaltschmidt, and C. Kaltschmidt NF-kappaB in the nervous system Cold Spring Harb. Perspect. Biol. 1 2009 a001271
16. K. Kolmus, J. Tavernier, and S. Gerlo beta2-Adrenergic receptors in immunity and inflammation: stressing NF-kappaB Brain Behav. Immun. 45 2015 297 310
17. L. Lin, X. Liu, J. Xu, L. Weng, J. Ren, J. Ge, and Y. Zou High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K/Akt pathway J. Cell. Mol. Med. 19 2015 1929 1938
18. X. Liu, Z. Wu, K. Yang, H. Ding, and Y. Wu Quantitative analysis combined with chromatographic fingerprint for comprehensive evaluation of Danhong injection using HPLC-DAD J. Pharm. Biomed. Anal. 76 2013 70 74
19. B. London Natriuretic peptides and cardiac hypertrophy J. Am. Coll. Cardiol. 48 2006 506 507
20. R.C. Lyon, F. Zanella, J.H. Omens, and F. Sheikh Mechanotransduction in cardiac hypertrophy and failure Circ. Res. 116 2015 1462 1476
21. J.E. Manson, and S.S. Bassuk Biomarkers of cardiovascular disease risk in women Metabolism: Clin. Exp. 64 2015 S33 S39
22. M.S. Marber, B. Rose, and Y. Wang The p38 mitogen-activated protein kinase pathway - a potential target for intervention in infarction, hypertrophy, and heart failure J. Mol. Cell. Cardiol. 51 2011 485 490
23. J.M. McLenachan, and H.J. Dargie Left ventricular hypertrophy as a factor in arrhythmias and sudden death Am J. Hypertens. 2 1989 128 131
24. S. Moreau, J.N. DaSilva, A. Valdivia, and P. Fernando N-[C-11]-methyl-Hydroxyfasudil is a potential biomarker of cardiac hypertrophy Nucl. Med. Biol. 42 2015 192 197
25. C. Morisco, D.C. Zebrowski, D.E. Vatner, S.F. Vatner, and J. Sadoshima Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart J. Mol. Cell. Cardiol. 33 2001 561 573
26. A.J. Muslin MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets Clin. Sci. 115 2008 203 218
27. K. Nishigaki, M. Tomita, K. Kagawa, T. Noda, S. Minatoguchi, H. Oda, S. Watanabe, N. Morita, K. Nakao, and H. Fujiwara Marked expression of plasma brain Natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy J. Am. Coll. Cardiol. 28 1996 1234 1242
28. X. Peng, R. Chen, Y. Wu, B. Huang, C. Tang, J. Chen, Q. Wang, Q. Wu, J. Yang, H. Qiu, and Q. Jiang PPARgamma-PI3K/AKT-NO signal pathway is involved in Cardiomyocyte hypertrophy induced by high glucose and insulin J. Diabetes Complic. 29 2015 755 760
29. R.K. Perera, J.U. Sprenger, J.H. Steinbrecher, D. Hubscher, S.E. Lehnart, M. Abesser, K. Schuh, A. El-Armouche, and V.O. Nikolaev Microdomain switch of cGMP-regulated Phosphodiesterases leads to ANP-induced augmentation of beta-adrenoceptor-stimulated contractility in early cardiac hypertrophy Circ. Res. 116 2015 1304 1311
30. N.D. Perkins Integrating cell-signalling pathways with NF-kappaB and IKK function Nat. Rev. Mol. Cell Biol. 8 2007 49 62
31. Q. Ren-an, L. Juan, L. Chuyuan, F. Wenjuan, H. Chunyan, Y. Xuemei, H. Lin, and N. Hong Study of the protective mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia/reperfusion injury via the Akt-eNOS signaling pathway in rats J. Ethnopharmacol. 156 2014 190 198
32. A. Rohini, N. Agrawal, C.N. Koyani, and R. Singh Molecular targets and regulators of cardiac hypertrophy Pharmacol. Res: Off. J. Italian Pharmacol. Soc. 61 2010 269 280
33. S.P. Romaine, M. Tomaszewski, G. Condorelli, and N.J. Samani MicroRNAs in cardiovascular disease: an introduction for clinicians Heart 101 2015 921 928
34. S. Rubattu, G. Bigatti, A. Evangelista, C. Lanzani, R. Stanzione, L. Zagato, P. Manunta, S. Marchitti, V. Venturelli, G. Bianchi, M. Volpe, and P. Stella Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension J. Am. Coll. Cardiol. 48 2006 499 505
35. S.T. Smale Dimer-specific regulatory mechanisms within the NF-kappaB family of transcription factors Immunol. Rev. 246 2012 193 204
36. M.A. Song, A.N. Paradis, M.S. Gay, J. Shin, and L. Zhang Differential expression of microRNAs in ischemic heart disease Drug Discov. Today 20 2015 223 235
37. X. Su, X. Zhi, T. Cui, Q. Zheng, S. Wang, Y. Cao, C. Cui, and W. Feng Vasorelaxant activities of Danhong injection and their differential effects on the rat abdominal aorta and mesenteric artery J. Cardiovasc. Pharmacol. 65 2015 62 71
38. R.R. Sun, L. Lu, M. Liu, Y. Cao, X.C. Li, H. Liu, J. Wang, and P.Y. Zhang Biomarkers and heart disease Eur. Rev. Med. Pharmacol. Sci. 18 2014 2927 2935
39. X. Tan, J. Li, X. Wang, N. Chen, B. Cai, G. Wang, H. Shan, D. Dong, Y. Liu, X. Li, F. Yang, X. Li, P. Zhang, X. Li, B. Yang, and Y. Lu Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway Int. J. Biol. Sci. 7 2011 383 389
40. Y. Tang, M. Wang, X. Le, J. Meng, L. Huang, P. Yu, J. Chen, and P. Wu Antioxidant and Cardioprotective effects of Danshensu (3-(3, 4-Dihydroxyphenyl)-2-Hydroxy-propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats Phytomed.: Int. J. Phytother. Phytopharm. 18 2011 1024 1030
41. A.W. Tank, and D.L. Wong Peripheral and central effects of circulating catecholamines. comprehensive Physiology 5 2015 1 15
42. Y.C. Tien, J.Y. Lin, C.H. Lai, C.H. Kuo, W.Y. Lin, C.H. Tsai, F.J. Tsai, Y.C. Cheng, W.H. Peng, and C.Y. Huang Carthamus tinctorius L. prevents LPS-induced TNFalpha signaling activation and cell apoptosis through JNK1/2-NFkappaB pathway inhibition in H9c2 Cardiomyoblast cells J. Ethnopharmacol. 130 2010 505 513
43. T.G. von Lueder, B.H. Wang, A.R. Kompa, L. Huang, R. Webb, P. Jordaan, D. Atar, and H. Krum Angiotensin receptor Neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy Circulation: Heart Fail. 8 2014 71 78
44. S.B. Wachter, and E.M. Gilbert Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application Cardiology 122 2012 104 112
45. S. Wang, H. Guo, X. Wang, L. Chai, L. Hu, T. Zhao, B. Zhao, X. Tan, and F. Jia Pretreatment with Danhong injection protects the brain against ischemia-reperfusion injury Neural Regen. Res. 9 2014 1453 1459
46. X. Wang, and N.S. Dhalla Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure Mol. Cell. Biochem. 214 2000 131 155
47. Wang, Y., Gao, L.N., Cui, Y.L., Jiang, H.L., 2014b. Protective effect of danhong injection on acute hepatic failure induced by lipopolysaccharide and d-galactosamine in mice. Evidence-based complementary and alternative medicine: eCAM 2014, 153902.
48. Xiao, R.P., 2001. Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins. Science's STKE: signal transduction knowledge environment 2001, re15.
49. T. Yamazaki, and Y. Yazaki Molecular basis of cardiac hypertrophy Z. Fur Kardiol. 89 2000 1 6
50. X.J. Yu, D.M. Zhang, L.L. Jia, J. Qi, X.A. Song, H. Tan, W. Cui, W. Chen, G.Q. Zhu, D.N. Qin, and Y.M. Kang Inhibition of NF-kappa B activity in the hypothalamic Paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress Toxicol. Appl. Pharmacol. 284 2015 315 322
51. X.J. Yu, D.M. Zhang, L.L. Jia, J. Qi, X.A. Song, H. Tan, W. Cui, W. Chen, G.Q. Zhu, D.N. Qin, and Y.M. Kang Inhibition of NF-kappaB activity in the hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress Toxicol. Appl. Pharmacol. 284 2015 315 322
52. Y. Zhang, H. Wang, L. Cui, Y. Zhang, Y. Liu, X. Chu, Z. Liu, J. Zhang, and L. Chu Continuing treatment with Salvia miltiorrhiza injection attenuates myocardial fibrosis in chronic iron-overloaded mice PloS One 10 2015 e0124061
53. W. Zhu, A.Y. Woo, Y. Zhang, C.M. Cao, and R.P. Xiao Beta-adrenergic receptor subtype signaling in the heart: from bench to the bedside Curr. Top. Membr. 67 2011 191 204